Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant DisordersOrly R. Klein, Heather J. Symons, Diana Steppan et al.|Biology of Blood and Marrow Transplantation|2016Cited by 76
Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic MalignanciesOrly R. Klein, Heather J. Symons, Jessica Buddenbaum et al.|Biology of Blood and Marrow Transplantation|2016Cited by 73
Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adultsHeather J. Symons, Ephraim J. Fuchs, Marianna Zahurak et al.|Blood Advances|2020Cited by 73
Donor T cell DNMT3a regulates alloreactivity in mouse models of hematopoietic stem cell transplantationYiouli P. Ktena, Kenneth R. Cooke, Michael A. Koldobskiy et al.|Journal of Clinical Investigation|2022Cited by 15